With the prevalence of aberrations in the expression of TACC3 in the ovarian tumor arrays, we screened the coding sequence of the TACC3 gene in 76 ovarian cancer families that do not have mutations in known ovarian predisposition loci, such as BRCA1 and BRCA2 [1,2]. This evidence concerns the gene BRCA1 and ovarian neoplasm.